Log in
Book a free demo
H-1B Data › Employers › NGM Biopharmaceuticals, Inc.
Check another employer
H-1B Sponsor Profile

NGM Biopharmaceuticals, Inc. — H-1B Visa Sponsorship Data

18 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2025.

South San Francisco, CAActive FY2021–FY2025Full-Time RolesNot H-1B Dependent
● Data current through FY2025 · sourced from U.S. DOL OFLC, updated quarterly
I work at NGM Biopharmaceuticals, Inc.See what a DOL auditor would ask about your filingsConsidering a job here?Salaries, transfers and where roles are based
Sponsors H-1B?
Yes
18 certified LCAs
FY2025 filings
1
most recent disclosure year
Median H-1B salary
$112,550
typical $110,000–$124,405
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
15%
change-of-employer filings
Audit readiness Check another employer

4 items a DOL auditor would ask NGM Biopharmaceuticals, Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from NGM Biopharmaceuticals, Inc.'s own public LCA filings (FY2023–FY2025) — the same records an investigator pulls first.

0 need attention4 to watch3 clear
Watch
71% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 0% above the DOL prevailing wage across 7 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Watch
1 certified LCA (1 position) end within 180 days

Next end date: 2027-01-01. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.

Auditor asksWhich workers are on each expiring LCA, and is a superseding LCA already certified?
In your PAFSuperseding LCA, updated PAF entry and new posting notice for every position that continues.
Watch
30% of positions are amendments or material changes

Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.

Auditor asksFor each amendment: what changed, on what date, and was the new LCA certified before that date?
In your PAFAmended LCAs with dates aligned to the actual change; updated PAF entries.
Watch
22% of LCAs denied or withdrawn (FY2023–FY2025)

Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.

Auditor asksWere the workers on withdrawn LCAs re-covered by a valid certified LCA before continuing work?
In your PAFWithdrawal acknowledgements; superseding LCAs; PAF entries showing the transition.
Clear
6% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
2 worksites across 2 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you NGM Biopharmaceuticals, Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at NGM Biopharmaceuticals, Inc.?

Does NGM Biopharmaceuticals, Inc. sponsor H-1B visas?

Yes — NGM Biopharmaceuticals, Inc. sponsors H-1B workers, with 18 certified LCAs on file (FY2021–FY2025), including 1 in FY2025. The median certified salary is $112,550 (P25 $110,000, P75 $124,405). 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to NGM Biopharmaceuticals, Inc.

Salary range
Median $112,550, typical band $110,000–$124,405.
Transfers
15% transfer share — most sponsorship is for new or continuing roles.
Typical locations
South San Francisco, CA, Yuma, AZ.
Position type
100% of filings are full-time roles.
Common roles
Scientist I, Manager, Formulation &Amp; Drug Produc, Research Associate Ii.
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. NGM Biopharmaceuticals, Inc. has 18 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2025).

The median sponsored salary is $112,550, with a typical P25–P75 band of $110,000–$124,405 across certified LCAs.

Yes — 15% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

No — the employer attests it is not H-1B dependent on its LCA filings.

NGM Biopharmaceuticals, Inc. filed 1 certified LCAs in FY2025, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include South San Francisco, CA, Yuma, AZ.
Sponsorship data

NGM Biopharmaceuticals, Inc. H-1B data at a glance

Executive Summary

NGM Biopharmaceuticals, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2025).

  • Median certified salary is $112,550, typically $110,000–$124,405 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 15% — most filings are for new or continuing employment.
  • Worksite footprint spans 2 states and 2 cities.
  • Most-sponsored roles: Scientist I, Manager, Formulation &Amp; Drug Product, Research Associate Ii.
  • Filed 1 certified LCAs in FY2025, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$75,400
$180,014
P25$110,000
Median$112,550
P75$124,405

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
6%
Level II
82%
Level III
12%
Level IV
0%

Levels I–IV are DOL prevailing-wage experience tiers; 12% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
6
FY2022
5
FY2023
4
FY2024
2
FY2025
1
Fiscal yearCertifiedDeniedWithdrawnTotal
FY20216006
FY20225005
FY20234026
FY20242002
FY20251001

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2024 ›FY2025 ›

All LCA filings

18 filings
Job titleSalaryLevelLocationFiledStatus
Senior Scientist
I-200-25030-652637
$140,300/yrIISouth San Francisco, CAJan 29, 2025Certified
Senior Research Associate I
I-200-24101-875330
$101,816/yrIISouth San Francisco, CAApr 10, 2024Certified
Senior Scientist
I-200-24101-871097
$132,000/yrIISouth San Francisco, CAApr 09, 2024Certified
Senior Research Associate
I-200-23236-293250
$101,816/yrIISouth San Francisco, CAAug 24, 2023Certified
Associate Scientist
I-200-23227-265237
$121,621/yr—South San Francisco, CAAug 15, 2023Certified
Sr. Research Associate II
I-200-23173-137559
$111,072/yrIISouth San Francisco, CAJun 22, 2023Certified
Scientist II
I-200-23152-071804
$113,000/yrIISouth San Francisco, CAJun 01, 2023Certified, withdrawn
Scientist I
I-200-23114-959754
$112,100/yrIISouth San Francisco, CAApr 24, 2023Certified, withdrawn
Sr. Clinical Trial Management Associate
I-200-23040-763932
$110,469/yrIIYuma, AZFeb 09, 2023Certified
Associate Director, Clinical Operations
I-200-22208-379156
$180,014/yr—South San Francisco, CAJul 27, 2022Certified
Scientist II
I-200-22158-253064
$120,615/yrIISouth San Francisco, CAJun 07, 2022Certified
Research Associate II
I-200-22109-085910
$80,155/yrIISouth San Francisco, CAApr 19, 2022Certified
Sr. Clinical Trial Management Associate
I-200-22098-051910
$126,831/yr—South San Francisco, CAApr 08, 2022Certified
Scientist I
I-200-22094-035979
$110,000/yrIISouth San Francisco, CAApr 04, 2022Certified
Research Associate II
I-200-21112-250123
$75,400/yrISouth San Francisco, CAApr 22, 2021Certified
Scientist I
I-200-21112-250118
$120,000/yrIISouth San Francisco, CAApr 22, 2021Certified
Scientist I
I-200-21056-102348
$110,000/yrIISouth San Francisco, CAFeb 25, 2021Certified
Manager, Formulation & Drug Product
I-200-21007-000838
$124,405/yrIIISouth San Francisco, CAJan 07, 2021Certified

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How NGM Biopharmaceuticals, Inc. sponsors H-1B talent

Petition Mix

New employment  50%Transfer (change of employer)  15%Continued employment  5%Amendments & other  30%
Majority new-employment filings — NGM Biopharmaceuticals, Inc. primarily sponsors fresh H-1B cases.

Worker positions by LCA filing purpose, summed across FY2021–FY2025 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Apr and Jan — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
100%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Scientist I
5 · $112,420
Manager, Formulation &Amp; Drug Pr
2 · $124,405
Research Associate Ii
2 · $77,778
Scientist Ii
2 · $116,808
Senior Scientist
2 · $136,150

Top worksite locations

2 states · 2 cities

South San Francisco, CA
19
Yuma, AZ
1
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore the H-1B compliance platform →
Explore more

Similar H-1B sponsors by filing volume

Diasorin Molecular Llc18 LCAs
Levanture Inc18 LCAs
Suny Plattsburgh18 LCAs
Abtech Solutions Llc18 LCAs
Elvinger Sarl Pllc18 LCAs
Afflux Systems Llc18 LCAs

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
NGM Biopharmaceuticals, Inc. · audit readiness
0 need attention4 to watch3 clear
Get my private gap check →